Scientific Basis of HemoHIM’s Fatigue-Reducing Effects
What is the New Functionality?
"The Mixed Extracts in HemoHIM Including Angelica Gigas" has been officially recognized for its dual functionality: improving immune function and reducing fatigue.
In September 2023, HemoHIM mixed extracts received approval from the Ministry of Food and Drug Safety (MFDS) for its fatigue-reducing functionality. This makes it the first individually approved ingredient to secure this dual functionality, a milestone achieved six years after launching the "Project to Develop Technology for Long-Lasting HemoHIM" in 2017.
Scientific Basis
The combination of immune support and fatigue reduction is backed by solid scientific evidence regarding antioxidation.
- Oxidative Stress: Excess free radicals (ROS) can damage cells, accelerate aging, and weaken immunity.
- Antioxidant Effect: HemoHIM mixed extracts help neutralize free radicals, protecting cells and reducing oxidative stress.
- FSS (Fatigue Severity Scale)
- MFI (Multidimensional Fatigue Inventory)
Numerous studies have shown that HemoHIM not only enhances immune function by activating NK cells and boosting cytokine production but also helps reduce fatigue through its antioxidant effects.
Proven Results
Kolmar BNH demonstrated these effects through extensive research, resulting in the publication of three SCIE-indexed papers.
Clinical Trial Results
Studies on healthy adults aged 30 to 59 suffering from fatigue showed significant improvements in:
These results provide strong scientific evidence of HemoHIM’s efficacy in improving fatigue and have been patented in South Korea, Russia, and the United States.
Conclusion
Experience the dual power of immunity enhancement and fatigue reduction with Atomy HemoHIM. Backed by science, proven by research.
Disclaimer: HemoHIM is a health functional food and is not intended to diagnose, treat, cure, or prevent any disease.